Format
Sort by
Items per page

Send to

Choose Destination

Best matches for pregabalin OR 3-isobutyl GABA OR 3-Isobutyl GABA OR Pregabalin:

How addictive are gabapentin and pregabalin? A systematic review. Bonnet U et al. Eur Neuropsychopharmacol. (2017)

Trial of Pregabalin for Acute and Chronic Sciatica. Mathieson S et al. N Engl J Med. (2017)

Pregabalin and heart failure: A population-based study. Ho JM et al. Pharmacoepidemiol Drug Saf. (2017)

Search results

Items: 1 to 20 of 39

  • Filters activated: AIDS. Clear all to show 3329 items.
1.

Pregabalin for neuropathic pain in adults.

Derry S, Bell RF, Straube S, Wiffen PJ, Aldington D, Moore RA.

Cochrane Database Syst Rev. 2019 Jan 23;1:CD007076. doi: 10.1002/14651858.CD007076.pub3.

PMID:
30673120
2.

Pharmacokinetic Considerations with the Use of Antiepileptic Drugs in Patients with HIV and Organ Transplants.

Asconapé JJ.

Curr Neurol Neurosci Rep. 2018 Oct 9;18(12):89. doi: 10.1007/s11910-018-0897-4. Review.

PMID:
30302572
3.

Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain.

Blair HA.

Drugs. 2018 Sep;78(14):1489-1500. doi: 10.1007/s40265-018-0982-7.

PMID:
30251173
4.

Pregabalin misuse in methadone maintenance treatment patients in Israel: Prevalence and risk factors.

Sason A, Adelson M, Schreiber S, Peles E.

Drug Alcohol Depend. 2018 Aug 1;189:8-11. doi: 10.1016/j.drugalcdep.2018.04.025. Epub 2018 May 29.

PMID:
29857329
5.

Interventions for Neuropathic Pain: An Overview of Systematic Reviews.

Dosenovic S, Jelicic Kadic A, Miljanovic M, Biocic M, Boric K, Cavar M, Markovina N, Vucic K, Puljak L.

Anesth Analg. 2017 Aug;125(2):643-652. doi: 10.1213/ANE.0000000000001998. Review.

PMID:
28731977
6.

Niflumic acid, a TRPV1 channel modulator, ameliorates stavudine-induced neuropathic pain.

Marwaha L, Bansal Y, Singh R, Saroj P, Sodhi RK, Kuhad A.

Inflammopharmacology. 2016 Dec;24(6):319-334. Epub 2016 Oct 18.

PMID:
27757590
7.

[Transverse myelitis associated with toxocariasis and the importance of locally produced antibodies for diagnosis].

Ural S, Özer B, Gelal F, Dirim Erdoğan D, Sezak N, Balık R, Demirdal T, Korkmaz M.

Mikrobiyol Bul. 2016 Jul;50(3):478-83. Turkish.

8.

Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV: a systematic review.

Merlin JS, Bulls HW, Vucovich LA, Edelman EJ, Starrels JL.

AIDS Care. 2016 Dec;28(12):1506-1515. Epub 2016 Jun 7. Review.

9.

Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain.

Burness CB, McCormack PL.

Drugs. 2016 Jan;76(1):123-34. doi: 10.1007/s40265-015-0520-9. Review.

PMID:
26666418
10.

Idiopathic Ophthalmodynia and Idiopathic Rhinalgia: A Prospective Series of 16 New Cases.

Pareja JA, Montojo T, Guerrero ÁL, Álvarez M, Porta-Etessam J, Cuadrado ML.

Headache. 2015 Nov-Dec;55(10):1430-5. doi: 10.1111/head.12609. Epub 2015 Jul 21.

PMID:
26198298
11.

Back to the future: the need to resolve analgesic efficacy in human immunodeficiency virus neuropathy.

Dworkin RH, McDermott MP.

Pain. 2014 Oct;155(10):1913-5. doi: 10.1016/j.pain.2014.07.015. Epub 2014 Jul 24. No abstract available.

PMID:
25067836
12.

A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy.

Simpson DM, Rice AS, Emir B, Landen J, Semel D, Chew ML, Sporn J.

Pain. 2014 Oct;155(10):1943-54. doi: 10.1016/j.pain.2014.05.027. Epub 2014 Jun 4.

PMID:
24907403
13.

Systematic review and meta-analysis of pharmacological therapies for pain associated with postherpetic neuralgia and less common neuropathic conditions.

Snedecor SJ, Sudharshan L, Cappelleri JC, Sadosky A, Desai P, Jalundhwala Y, Botteman M.

Int J Clin Pract. 2014 Jul;68(7):900-18. doi: 10.1111/ijcp.12411. Epub 2014 Apr 2. Review.

PMID:
24698515
14.

Posttraumatic and postsurgical neuropathic pain responsive to treatment with capsaicin 8% topical patch.

Zis P, Apsokardos A, Isaia C, Sykioti P, Vadalouca A.

Pain Physician. 2014 Mar-Apr;17(2):E213-8.

15.

Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs.

Freeman R, Baron R, Bouhassira D, Cabrera J, Emir B.

Pain. 2014 Feb;155(2):367-76. doi: 10.1016/j.pain.2013.10.023. Epub 2013 Oct 25.

PMID:
24472518
16.

HIV-related neuropathy: current perspectives.

Schütz SG, Robinson-Papp J.

HIV AIDS (Auckl). 2013 Sep 11;5:243-51. doi: 10.2147/HIV.S36674. Review.

17.

Management of painful neuropathies.

Brix Finnerup N, Hein Sindrup S, Staehelin Jensen T.

Handb Clin Neurol. 2013;115:279-90. doi: 10.1016/B978-0-444-52902-2.00017-5. Review.

PMID:
23931787
18.

Safe Treatment of Seizures in the Setting of HIV/AIDS.

Siddiqi O, Birbeck GL.

Curr Treat Options Neurol. 2013 Aug;15(4):529-43. doi: 10.1007/s11940-013-0237-6.

19.

Clinical practice guidelines for management of neuropathic pain: expert panel recommendations for South Africa.

Chetty S, Baalbergen E, Bhigjee AI, Kamerman P, Ouma J, Raath R, Raff M, Salduker S; South African Expert Panel.

S Afr Med J. 2012 Mar 8;102(5):312-25.

PMID:
22554341
20.

Response-adaptive designs for continuous treatment responses in phase III clinical trials: A review.

Biswas A, Bhattacharya R.

Stat Methods Med Res. 2016 Feb;25(1):81-100. doi: 10.1177/0962280212441424. Epub 2012 Mar 16. Review.

PMID:
22425657

Supplemental Content

Loading ...
Support Center